IMM 01 and IMM 06: Pharmaceutical Care I and II – Patient-Centred Pharmaceutical Care and Assessment Flashcards

1
Q

What is pharmaceutical care?

A

a patient-centred practice in which the practitioner assumes responsibility for a patient’s drug-related needs and is held accountable for this commitment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the elements of pharmaceutical care? (4)

A
  • medication related – use and management of medications
  • care that is directly provided to the patient – focused on patient needs, values, concerns, questions, well-being
  • provided to produce definite health outcomes
  • provider accepts personal responsibility for the outcomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the outcomes of pharmaceutical care? (4)

A
  • cure of disease/condition
  • arrest or slow a disease process – ie. cancer, diabetes, arthritis
  • prevent a disease or symptoms – ie. osteoporosis, myocardial infarction, stroke
  • eliminate or reduce symptoms – ie. pain management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 5 aspects of patient-centred care?

A
  • personal concern for well-being of patient
  • establishment of a trusting, respectful, professional, caring, ethical relationship
  • commitment to always act in best interest of patient – their health-related needs, preferences, goals, and values should be incorporated in all clinical decisions
  • cooperation with other healthcare professionals and patient to optimize care
  • patient is at centre of all decision-making
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 components of the pharmaceutical care process cycle?

A
  • assessment
  • care plan
  • evaluation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Assessment

A

systematic review of patient’s drug therapy needs

  • gather, synthesize and interpret relevant patient information
  • determine whether patient’s drug-related needs are being met (NESA)
  • identify, justify and prioritize drug therapy problems (DTPs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Care Plan

A

involves agreeing on the goals of therapy and selecting interventions to achieve those goals – collaborative process with the patient, aiming to align their needs and preferences with the treatment plan

  • identify desired outcomes and goals of therapy
  • identify, assess, justify and prioritize feasible therapeutic alternatives
  • develop, justify and implement patient-specific recommendations – make clinical decisions based on the available evidence, patient values and preferences, and our professional expertise
  • design and implement a therapeutic monitoring plan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Evaluation

A

involves following up to assess the goals that were set and determining if they’ve been achieved, and looking for any new drug therapy problems that may have arisen

  • important as it determines the effectiveness of the care plan and associated interventions in achieving the goals of therapy for each of the patient’s medical conditions
  • document actual patient outcomes
  • assess whether outcomes are being achieved (→ return to assessment step PRN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the outcomes of Assessment?

A
  • complete and accurate problem identification
  • selection of the best recommendations for your patient (care plan)
  • identification of appropriate monitoring parameters (care plan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the ‘thought process’?

A

a structured, logical, and systemic approach that allows the practitioner to assess whether patient’s drug therapy needs are being met for each of the patient’s medical conditions

  • provides you with a rationale process for making sound clinical decisions
  • used to assess each medical condition a patient has/may have
  • responses to questions in the thought process may be provided by interviewing the patient, medical records, literature
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Necessary

A

explain whether medication (prescription/non-prescription, over-the-counter (OTC), natural health products (NHP)) is necessary to treat this medical condition

  • describe this patient’s medical condition/diagnosis in terms of pathophysiology, signs/symptoms, causes, risk factors, etc.
  • describe patient’s signs/symptoms/lab values and whether they are consistent with the medical condition
  • explain whether any of the current medical conditions, medications, or interactions contribute to this patient’s medical condition
  • articulate the desired therapeutic outcomes for this condition
  • describe the therapeutic regimens (ie. both pharmacological and non-pharmacological) that are recommended (ie. commonly used) to achieve the therapeutic outcomes
  • identify drug therapy the patient is already receiving – all medication patient currently taking AND any new prescriptions patient has presented
  • discuss any additional drug therapy that may be required – consider preventative therapy, untreated condition, synergistic therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effectiveness

A

explain whether this patient’s drug therapy is effective for this condition, discuss whether drug therapy is achieving the therapeutic outcomes for this condition, compare desired outcomes with actual patient status

  • identify whether drug is indicated for the condition and describe the mechanism of action (MOA) of the medication to treat condition
  • discuss whether drug is most effective drug to treat condition (describe more effective alternatives, if available)
  • discuss whether drug therapy(ies) are optimal / appropriate for this patient – consider generic drug name, dose, route, frequency, dosage form, duration, max daily dose (PRN meds)
  • discuss whether the clinical onset of action is appropriate, and describe clinical expectations of drug in achieving therapeutic outcome(s)
  • describe mechanism of any severe interactions (drug-drug, drug-food, drug-NHP, etc.) that can make the drug less effective that may result in modification of therapy – identify whether the patient is taking another product that would alter the effectiveness of this drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Safety

A

discuss the safety of this patient’s therapy(ies) for this condition, describe whether this patient is experiencing/at risk of experiencing an undesirable effect (adverse drug reactions or drug toxicity) from this drug

  • describe the mechanism of any contraindications the patient has to this medication
  • describe the mechanism of any adverse drug reactions (ADR) the patient is experiencing or may experience (including side effects)
  • discuss any duplication of therapy and whether it is harmful, or potentially harmful, to the patient
  • describe the mechanism of any severe interactions (drug-drug, drug-food, drug-condition, drug-NHP, etc.) that may result in modification of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adherence

A

discuss this patient’s ability to adhere to therapy

  • availability of product
  • lifestyle
  • complexity of regimen
  • finances
  • cultural or personal values/beliefs
  • dosage form
  • language barrier
  • physical or mental challenges
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Unmet Needs

A

would the patient benefit from any other interventions

  • prophylactic therapy (ie. vaccinations)
  • non-drug measures
  • referrals
  • other medical condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly